Quantifying mutations in healthy blood

See allHide authors and affiliations

Science  27 Mar 2020:
Vol. 367, Issue 6485, pp. 1426-1427
DOI: 10.1126/science.aba9891

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


Over time, somatic mutations accrue during normal cell division and tissue self-renewal. The patterns of age-associated somatic mutation have been perhaps most extensively characterized in the blood. Although many mutations are functionally benign, a subset represents premalignant initiating events in hematopoietic stem cells that result in clonal expansion. This clonal hematopoiesis confers an increased risk of hematologic malignancy (after the accrual of additional cooperating mutations), as well as cardiovascular disease and overall mortality (1). On page 1449 of this issue, Watson et al. (2) investigate the clonal architecture and evolutionary dynamics of healthy blood by analyzing targeted DNA sequences of ∼50,000 blood cancer–free individuals. They find that positive selection for beneficial mutations, rather than neutral genetic drift, dictates the genetic diversity of normal blood. The identification of mutant clones and their associated fitness benefits could improve disease risk stratification.

View Full Text

Stay Connected to Science

Editor's Blog